10-Q/A XBRL

OXIS QUARTERLY REPORT JUNE 30, 2011 AMENDED

Company: GT Biopharma, Inc.
Filed: September 12, 2011
Period of Report: June 30, 2011
Accession Number: 0001513160-11-000058

View Document ↗ View on SEC.gov ↗